Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
Kreitman, R. J., Stetler-Stevenson, M., Margulies, I., Noel, P., FitzGerald, D. J.P., Wilson, W. H., Pastan, I.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2008.20.2630
Date:
June, 2009
File:
PDF, 250 KB
english, 2009